Lensar Inc (LNSR) Stock Price, Quote & News

Company Profile

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System. The company offers LENSAR Laser System which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cat...

Industry: Medical Devices

Sector: Healthcare

Phone: 888 536 7271

Website: www.lensar.com

Address:

2800 Discovery Drive, Orlando, United States

HypnoTrader Jun. 5 at 6:58 PM

$LNSR merger caput?

0 · Reply

QuiverQuant Jun. 2 at 9:50 PM

LENSAR, Inc. Grants 3,090 Restricted Stock Units to New Employees as Inducement for Employment Read more on $LNSR: https://www.quiverquant.com/news/LENSAR%2C+Inc.+Grants+3%2C090+Restricted+Stock+Units+to+New+Employees+as+Inducement+for+Employment

0 · Reply

HypnoTrader May. 24 at 1:58 AM

$LNSR They get a delay in the merger from FTC and do not bother issuing a press release. WTF? No wonder the stock dropped....

0 · Reply

Chiroptera_Capital Apr. 16 at 8:55 PM

$SIBN medtech M&A is heating up. $LNSR and $ICAD are two medtech nanocaps that have been taken out in 2025. Si-Bone in 2026?

1 · Reply

Chiroptera_Capital Apr. 16 at 3:47 AM

$ICAD $LNSR both acquired… I’m wrong plenty but this call feels good

1 · Reply

smartkarma Apr. 14 at 1:20 AM

$LNSR | Strategic Acquisitions, Merger Developments, and Takeover Bids: Key Updates "Lensar (LNSR) is being acquired by Alcon for $14/share plus a CVR up to $2.75/share, with closing expected in H2 2024. OCI N.V. announced a $1BN extraordinary cash distribution..." - Special Situation Investments (Special Situation Investments) Read more: https://www.smartkarma.com/insights/strategic-acquisitions-merger-developments-and-takeover-bids-key-updates

0 · Reply

smartkarma Apr. 10 at 10:39 AM

$LNSR | Alcon's Strategic Acquisition of Lensar: Potential 23% Upside with CVR Payout and Antitrust Considerations "Lensar is being acquired by Alcon for $14/share in cash plus a CVR worth up to $2.75/share." - Special Situation Investments (Special Situation Investments) Read more: https://www.smartkarma.com/insights/alcon-s-strategic-acquisition-of-lensar-potential-23-upside-with-cvr-payout-and-antitrust-considerations

0 · Reply

NVDAMillionaire Mar. 29 at 1:34 AM

Digging ALLY System's potential. FDA clearance in 2022 looks promising. Robotic tech could disrupt cataract surgery market. Watching closely for next quarter's performance. $LNSR might be an interesting play. essential takeaways from recent developments: https://beyondspx.com/article/lensar-inc-nasdaq-lnsr-a-robotic-revolution-in-cataract-treatment

0 · Reply

OpenOutcrier Mar. 24 at 8:01 PM

RECAP 3/24 +Pos Comments: $TSLA + New Street RECAP 3/24 -Neg Comments: $DOOO - Edgwater Research $DOCS - Lauren Balik $OPT - Oppy $LNSR - Lake St Capital Live Breaking trading news www.openoutcrier.com

0 · Reply

JarvisFlow Mar. 24 at 4:19 PM

Lake Street updates rating for LENSAR ( $LNSR ) to Hold, target set at 16 → 15.

0 · Reply

LENSAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LENSAR, Inc. - LNSR

ALC

Jun 2, 2025, 4:01 PM EDT - 26 days ago

LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 8, 2025, 7:00 AM EDT - 7 weeks ago

LENSAR Reports First Quarter 2025 Results and Provides Business Update

Feb 28, 2025, 1:05 PM EST - 4 months ago

LENSAR, Inc. (LNSR) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 7:00 AM EST - 4 months ago

LENSAR Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update

Feb 19, 2025, 12:00 PM EST - 4 months ago

LENSAR to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 27, 2025

Feb 5, 2025, 4:36 AM EST - 5 months ago

Medical Devices Firm Lensar Surges Ahead On Robotic Technology

Nov 26, 2024, 8:00 AM EST - 7 months ago

LENSAR to Participate in the BTIG 4th Annual Ophthalmology Day

Nov 9, 2024, 1:16 AM EST - 8 months ago

LENSAR, Inc. (LNSR) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 7:00 AM EST - 8 months ago

LENSAR Reports Third Quarter 2024 Results and Provides Business Update

Oct 31, 2024, 7:00 AM EDT - 8 months ago

LENSAR to Report Third Quarter 2024 Financial Results on Thursday, November 7, 2024

Oct 8, 2024, 8:00 AM EDT - 9 months ago

One Millionth Procedure Completed Using LENSAR's Cataract Laser Systems

Sep 4, 2024, 8:00 AM EDT - 10 months ago

LENSAR to Participate in Two Upcoming Investor Conferences

Aug 10, 2024, 12:15 AM EDT - 11 months ago

LENSAR, Inc. (LNSR) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 7:00 AM EDT - 11 months ago

LENSAR Reports Second Quarter 2024 Results and Provides Business Update

Aug 7, 2024, 7:00 AM EDT - 11 months ago

LENSAR Announces Certification for the ALLY® Adaptive Cataract Treatment System in the European Union

Aug 1, 2024, 7:00 AM EDT - 11 months ago

LENSAR to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024

May 23, 2024, 8:00 AM EDT - 1 year ago

LENSAR to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference

May 11, 2024, 3:50 PM EDT - 1 year ago

LENSAR, Inc. (LNSR) Q1 2024 Earnings Call Transcript

May 9, 2024, 7:00 AM EDT - 1 year ago

LENSAR Reports First Quarter 2024 Results and Provides Business Update

May 2, 2024, 8:00 AM EDT - 1 year ago

LENSAR to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024

Mar 4, 2024, 10:36 AM EST - 1 year ago

LENSAR, Inc. (LNSR) Q4 2023 Earnings Call Transcript

Mar 4, 2024, 7:00 AM EST - 1 year ago

LENSAR Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update

Feb 26, 2024, 8:00 AM EST - 1 year ago

LENSAR to Report Fourth Quarter and Full Year 2023 Financial Results on Monday, March 4, 2024

Nov 11, 2023, 12:32 PM EST - 1 year ago

LENSAR, Inc. (LNSR) Q3 2023 Earnings Call Transcript

Nov 9, 2023, 7:00 AM EST - 1 year ago

LENSAR Reports Third Quarter 2023 Results and Provides Business Update

Nov 2, 2023, 8:03 AM EDT - 1 year ago

LENSAR to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023

Aug 11, 2023, 6:04 PM EDT - 2 years ago

LENSAR, Inc. (LNSR) Q2 2023 Earnings Call Transcript

Aug 9, 2023, 7:00 AM EDT - 2 years ago

LENSAR Reports Second Quarter 2023 Results and Provides Business Update

Aug 2, 2023, 8:00 AM EDT - 2 years ago

LENSAR to Report Second Quarter 2023 Financial Results on Wednesday, August 9, 2023

Jul 24, 2023, 7:00 AM EDT - 2 years ago

LENSAR® Reports Adoption of ALLY® System in Multi-Center Ophthalmology Groups

May 15, 2023, 10:25 AM EDT - 2 years ago

LENSAR, Inc. (LNSR) Q1 2023 Earnings Call Transcript

May 15, 2023, 7:00 AM EDT - 2 years ago

LENSAR Reports First Quarter 2023 Results and Provides Business Update

May 10, 2023, 8:00 AM EDT - 2 years ago

LENSAR to Report First Quarter 2023 Financial Results on Monday, May 15, 2023

Mar 16, 2023, 9:33 AM EDT - 2 years ago

LENSAR, Inc. (LNSR) Q4 2022 Earnings Call Transcript

Mar 16, 2023, 7:00 AM EDT - 2 years ago

LENSAR Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update

Mar 9, 2023, 8:00 AM EST - 2 years ago

LENSAR to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 16, 2023

Feb 14, 2023, 7:00 AM EST - 2 years ago

LENSAR Announces Preliminary Fourth Quarter and Full Year 2022 Results

Nov 22, 2022, 8:00 AM EST - 2 years ago

LENSAR to Present at Two Upcoming Investor Conferences

Nov 12, 2022, 11:29 AM EST - 2 years ago

LENSAR, Inc. (LNSR) Q3 2022 Earnings Call Transcript

Nov 9, 2022, 7:00 AM EST - 2 years ago

LENSAR Reports Third Quarter 2022 Financial Results and Provides Business Update

Nov 2, 2022, 8:00 AM EDT - 2 years ago

LENSAR to Report Third Quarter 2022 Financial Results on Wednesday, November 9, 2022

Sep 8, 2022, 7:00 AM EDT - 3 years ago

LENSAR Announces Application for Certification of the ALLY™ Adaptive Cataract Treatment System in the EU

Aug 16, 2022, 7:00 AM EDT - 3 years ago

First Patients Treated with LENSAR's® ALLY™ Adaptive Cataract Treatment System

Aug 8, 2022, 10:59 AM EDT - 3 years ago

LENSAR, Inc. (LNSR) CEO Nicholas Curtis on Q2 2022 Results - Earnings Call Transcript

Aug 8, 2022, 7:00 AM EDT - 3 years ago

LENSAR Reports Second Quarter 2022 Financial Results and Provides Business Update

Aug 1, 2022, 8:00 AM EDT - 3 years ago

LENSAR to Report Second Quarter 2022 Financial Results on Monday, August 8, 2022

Jun 13, 2022, 9:14 AM EDT - 3 years ago

Why Lensar Shares Are Trading Higher Today

HypnoTrader Jun. 5 at 6:58 PM

$LNSR merger caput?

0 · Reply

QuiverQuant Jun. 2 at 9:50 PM

0 · Reply

HypnoTrader May. 24 at 1:58 AM

$LNSR They get a delay in the merger from FTC and do not bother issuing a press release. WTF? No wonder the stock dropped....

0 · Reply

Chiroptera_Capital Apr. 16 at 8:55 PM

$SIBN medtech M&A is heating up. $LNSR and $ICAD are two medtech nanocaps that have been taken out in 2025. Si-Bone in 2026?

1 · Reply

Chiroptera_Capital Apr. 16 at 3:47 AM

$ICAD $LNSR both acquired… I’m wrong plenty but this call feels good

1 · Reply

smartkarma Apr. 14 at 1:20 AM

0 · Reply

smartkarma Apr. 10 at 10:39 AM

0 · Reply

NVDAMillionaire Mar. 29 at 1:34 AM

0 · Reply

OpenOutcrier Mar. 24 at 8:01 PM

0 · Reply

JarvisFlow Mar. 24 at 4:19 PM

Lake Street updates rating for LENSAR ( $LNSR ) to Hold, target set at 16 → 15.

0 · Reply

HypnoTrader Mar. 24 at 3:43 PM

$LNSR so the market is valuing potential $2.75 at the end of 2027 + 3 months interest rate of $14 + potential for additional higher bids at a combined $. 32 premium to the buyout price of $14... fair enough.

0 · Reply

HypnoTrader Mar. 24 at 1:30 PM

$LNSR definitely a lawsuit. Class action, settlement. Maybe $500K to lawyers, 5-6 cents to shareholders... this is how it goes.

0 · Reply

Playthegame06 Mar. 24 at 1:25 PM

$LNSR people are selling. Not going to wait for any contingency payout! Total BS!!

0 · Reply

Playthegame06 Mar. 24 at 1:23 PM

$LNSR This SUCKS!!! I see lawsuits coming!!

0 · Reply

john_iii Mar. 24 at 1:06 PM

$LNSR BO for 14 per share - which looks less than the current price on the market and then "with an additional non-tradeable contingent value right offering up to $2.75 per share in cash, conditioned on achievement of 614,000 cumulative procedures with LENSAR’s products between January 1, 2026, and December 31, 2027" What kind of scam buyout is this?

1 · Reply